Yes, new data has started to trickle through and most of it is very very good. Successes for siRNA and for shRNA in blood, CNS, brain, virus and cancer. Other GT looking good too. I'm not worried about BLT's lack of recognition because when they do have success the market will react accordingly. A single shot cure for HCV will get the recognition it deserves.
